Labstat is recognized as the world’s leading nicotine-containing product testing laboratory specializing in analytical chemistry, in-vitro toxicology, microbiology, regulatory consulting and method development.
We are focused on what is important to our clients
Scientific Leadership, Experience and Solutions to Support Our Clients Diverse Needs
We have been testing nicotine containing products since 1976. During this period, our scientific personnel have acquired the most extensive technical experience in the industry, from testing Reduced Harm Products (e-cigarettes, e-liquids, heat-not-burn, smokeless products, lozenges and gums) to testing conventional tobacco products. This experience is deep-rooted, starting at the product research and development stage well before the product and technology is suited for market.
Our clients face many technical and regulatory challenges on a daily basis and we don’t believe our clients have to face them alone. We work together with our clients as partners to find solutions that are technically sound, cost effective and timely.
Most Comprehensive Testing and Consulting Capabilities in the World
Reduced Risk Products (RRPs)
Reduced Risk Products (RRPs)
Data You Can Trust
We have invested in the most advanced analytical instrumentation to meet the technical and regulatory challenges of the global markets we support.
Our infrastructure, IT systems and SOPs are governed by an extensive quality management system. Labstat is ISO 17025 accredited, follows 21 CFR Part 58 (Good Laboratory Practices) and OECD GLP.
Our validation process is designed to meet regulatory standards to ensure that submitted data is reliable and defensible. You can be confident in the data we produce, regardless of whether you are submitting data to the FDA (PMTA, MRTP, Substantial Equivalence), Health Canada, EU TPD, ANVISA or any other regulatory agency.